CSS LLC’s Biohaven Pharmaceutical Holding BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-232,400
Closed -$35.1M – 1322
2022
Q3
$35.1M Buy
232,400
+231,300
+21,027% +$34.3M 1.65% 6
2022
Q2
$161K Sell
1,100
-1,400
-56% -$179K 0.01% 833
2022
Q1
$296K Buy
+2,500
New +$312K 0.01% 757
2021
Q1
– Sell
-33,700
Closed -$2.89M – 1262
2020
Q4
$2.89M Buy
+33,700
New +$2.86M 0.11% 152

Other funds holding BHVN

CSS LLC's BHVN Position: Q4 2022 in Review

CSS LLC sold out of Biohaven Pharmaceutical Holding (BHVN) in Q4 2022, closing a stake of 194,903 shares — an estimated $29.5M sold.

CSS LLC first reported a position in BHVN in Q1 2020 and held it in 3 quarters. The position peaked at $29.5M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • CSS LLC reported no remaining Biohaven Pharmaceutical Holding position as of Q4 2022 after selling out during the quarter.
  • CSS LLC sold 194,903 Biohaven Pharmaceutical Holding shares in Q4 2022, an estimated $29.5M.
  • CSS LLC first reported a position in Biohaven Pharmaceutical Holding in Q1 2020 and held it in 3 quarters.
  • CSS LLC's Biohaven Pharmaceutical Holding position peaked at $29.5M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding as of Q4 2022.

Based on CSS LLC's 13F filing for Q4 2022, filed 14 Feb 2023.